hydroxyurea has been researched along with Sarcoidosis, Pulmonary in 1 studies
Sarcoidosis, Pulmonary: Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the benefit and corticosteroid-sparing potential of thalidomide in corticosteroid-dependent pulmonary sarcoidosis." | 9.12 | The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis. ( Byars, T; Cox, CE; Hartung, C; Judson, MA; Silvestri, J, 2006) |
| "To determine the benefit and corticosteroid-sparing potential of thalidomide in corticosteroid-dependent pulmonary sarcoidosis." | 5.12 | The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis. ( Byars, T; Cox, CE; Hartung, C; Judson, MA; Silvestri, J, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Judson, MA | 1 |
| Silvestri, J | 1 |
| Hartung, C | 1 |
| Byars, T | 1 |
| Cox, CE | 1 |
1 trial available for hydroxyurea and Sarcoidosis, Pulmonary
| Article | Year |
|---|---|
The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis.
Topics: Adrenal Cortex Hormones; Black or African American; Drug Therapy, Combination; Female; Humans; Hydro | 2006 |